Articles

With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with weight-loss drug questions

The more than two dozen tainted eye drops that the FDA warned could cause infection and vision loss have been traced back to an unsanitary factory, according to a report.

U.S. consumer sentiment fell in November for the fourth month in a row due to worries about higher interest rates as well as ongoing war in the Middle East.

China chip foundry giant Semiconductor Manufacturing International Corp. reported plunging profits and sales on Friday.

A bullish stock market indicator with a sterling track record arrived last week. And technical analysts on Wall Street haven't stopped talking about it.

Drugmaker set to expand Danish facilities amid ongoing Wegovy shortage.

British billionaire Sir Jim Ratcliffe is reportedly close to clinching a deal to become a minority stakeholder in Manchester United. 

As SoFi shares slid this week, two executives bought up stock.

Shares in Richemont led Europe's luxury goods sector lower on Friday, after the Swiss-based group said geopolitical angst and a weakening European economy had delivered lower than expected first-half profits.

Post Content

Plug Power's stock plummeted Friday, after another disappointing quarterly report prompted some analysts to bag their bullish calls.

Company will halt development of experimental depression treatment